10-Q - NeuroOne Medical Technologies Corporation | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

NeuroOne Medical Technologies Corporation reported Q1 2026 results with total revenue of $5.9M, consisting of $2.9M in product revenue and $3.0M in license revenue. The company generated a product gross profit of $1.6M but recorded an operating loss of $1.7M due to total operating expenses of $3.3M. Net loss for the quarter was $1.4M. The balance sheet shows total assets of $8.6M with cash and cash equivalents of $3.6M, while total liabilities stand at $2.2M. Operating activities used $3.1M in cash, resulting in a net decrease in cash of $3.0M for the quarter. The company ended the period with $6.6M in cash. No prior period comparisons are provided in the source data.

Key Takeaways

1Total revenue of $5.9M with $2.9M from products and $3.0M from licenses.

2Net loss of $1.4M for Q1 2026 with operating loss of $1.7M.

3Operating cash flow negative $3.1M, contributing to $3.0M net cash decrease.

4Cash balance of $6.6M at quarter end with total assets of $8.6M.

5Total operating expenses of $3.3M, including $1.9M SG&A and $1.4M R&D.

Key Financial Metrics

Revenue

$5.9M

Net Income

-$1.4M

Gross Profit

$1.6M

Operating Income

-$1.7M